In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

as a result of prior commercial sales of Vaxzevria® by AstraZeneca. We expect that this additional cash, when received, will enable us to fund our research and development plans further into the ...

This helped to offset a decline in AZ's COVID-19 vaccine Vaxzevria, which fell 48% to $451 million. Oncology put in another strong performance, rising 15% to $3.8 billion, with a 7% increase for ...

The healthy sales increase was bolstered by the timing of orders for AZ's COVID-19 vaccine Vaxzevria, which made $1.1 billion in the quarter but is expected to make less of a contribution in the ...

Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and ...

Covid vaccines left Aussie mother-of-two Ellie Sutton in such agony she 'prayed for death' and has considered euthanasia.

At close: 18 October at 4:46 pm GMT-3 ...

Barbara Obstoj-Cardwell is the Managing Editor of The Pharma Letter, which in 2010 acquired the archives of The Pharma Marketletter, a publication that Barbara owned since 1991 and prior to that ...